EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies

Rafał Bilski iD, Daria Kupczyk iD, Karolina Kaczorowska-Bilska, Halina Tkaczenko iD, Natalia Kurhaluk iD, Tomasz Kosmalski iD, Artur Słomka iD, Renata Studzińska iD

International Journal of Molecular Sciences · 25.03.2026 · 27 (7) · 3001

DOI: 10.3390/ijms27073001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.03.2026. Verfasst von Rafał Bilski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology and Biochemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Karłowicz Str. 24, 85-092 Bydgoszc…. Hauptthemen laut MEDLINE: Multiple Myeloma, Oxidative Stress, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by high metabolic activity, chronic endoplasmic reticulum stress, and persistent redox imbalance. Excessive immunoglobulin synthesis and adaptation to the hypoxic bone marrow microenvironment lead to sustained production of reactive oxygen species (ROS). Their excessive accumulation promotes genomic instability, disease progression, osteolytic bone disease, and resistance to therapy. Paradoxically, MM cells adapt to oxidative stress by activating antioxidant and metabolic defense mechanisms, including Nuclear factor erythroid 2-related factor 2 (NRF2)- and Heme Oxygenase 1 (HMOX1)-dependent pathways, metabolic reprogramming, and overexpression of ROS-scavenging enzymes such as peroxiredoxin 6 (PRDX6), allowing survival at the threshold of oxidative toxicity. Evidence indicates that biomarkers of oxidative stress—such as lipid and protein oxidation products, antioxidant enzyme activity, and the Oxidative Stress Score—correlate with disease stage, prognosis, and treatment response. Redox-modulating therapeutic strategies, including pharmacological ROS induction, inhibition of antioxidant defenses, and the use of natural pro-oxidant compounds, are emerging as promising adjuncts to standard MM therapies. Recent studies also highlight the gut microbiota as an indirect regulator of oxidative balance, immune modulation, and metabolic homeostasis in MM. This review summarizes current knowledge on oxidative stress in multiple myeloma, emphasizing its role in pathogenesis, drug resistance, biomarker development, and emerging therapeutic and supportive strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaOxidative StressBiomarkers, TumorHumansReactive Oxygen SpeciesOxidation-ReductionAnimalsAntioxidantsBiomarkers

Stichwörter der Autor:innen

CAPEPRDX6biomarkersgut microbiotamultiple myelomaoxidative stressproteasome inhibitorsreactive oxygen species

Substanzen

Reactive Oxygen SpeciesBiomarkers, TumorAntioxidantsBiomarkers

Autor:innen und Institutionen

  • Department of Medical Biology and Biochemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Karłowicz Str. 24, 85-092 Bydgoszcz, Poland.
  • Clinic of Hematology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, K. Ujejskiego Str. 75. 85-168 Bydgoszcz, Poland.
  • Institute of Biology, Pomeranian University in Słupsk, Arciszewski Str. 22b, 76-200 Slupsk, Poland.
  • Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasza Str. 2. 85-089 Bydgoszcz, Poland.
  • Department of Hematology and Oncology, National Medical Institute of the Ministry of Interior and Administration, 02-507 Warsaw, Poland.

ORCID-Profile: Rafał Bilski, Daria Kupczyk, Halina Tkaczenko, Natalia Kurhaluk, Tomasz Kosmalski, Artur Słomka, Renata Studzińska

Zitieren

APA

Bilski, R., Kupczyk, D., Kaczorowska-Bilska, K., Tkaczenko, H., Kurhaluk, N., Kosmalski, T., Słomka, A., & Studzińska, R. (2026). Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies. International Journal of Molecular Sciences, 27(7), 3001. https://doi.org/10.3390/ijms27073001

Vancouver

Bilski R, Kupczyk D, Kaczorowska-Bilska K, Tkaczenko H, Kurhaluk N, Kosmalski T, et al. Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies. International Journal of Molecular Sciences. 2026;27(7):3001. doi:10.3390/ijms27073001

BibTeX
@article{Bilski2026,
  author = {Bilski, Rafał and Kupczyk, Daria and Kaczorowska-Bilska, Karolina and Tkaczenko, Halina and Kurhaluk, Natalia and Kosmalski, Tomasz and Słomka, Artur and Studzińska, Renata},
  title = {Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3001},
  doi = {10.3390/ijms27073001}
}
Kostenlos starten →